According to Sangamo Therapeutics 's latest financial reports and stock price the company's current number of shares outstanding is 177,171,000. At the end of 2023 the company had 177,171,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.17 B | 7.56% |
2022 | 0.16 B | 13.02% |
2021 | 0.14 B | 2.99% |
2020 | 0.14 B | 22.09% |
2019 | 0.11 B | 13.57% |
2018 | 0.10 B | 20.32% |
2017 | 84.82 M | 19.92% |
2016 | 70.73 M | 0.82% |
2015 | 70.15 M | 2.26% |
2014 | 68.6 M | 10.89% |
2013 | 61.87 M | 16.81% |
2012 | 52.96 M | 0.85% |
2011 | 52.52 M | 16.2% |
2010 | 45.2 M | 9.75% |
2009 | 41.18 M | 0.63% |
2008 | 40.92 M | 5.15% |
2007 | 38.92 M | 14.69% |
2006 | 33.93 M | 33.46% |
2005 | 25.43 M | 1.04% |
2004 | 25.16 M | 1.43% |
2003 | 24.81 M | 1.24% |
2002 | 24.5 M | 0.78% |
2001 | 24.32 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 1,258.69% | ๐บ๐ธ USA |
Amgen AMGN | 535,000,000 | 201.97% | ๐บ๐ธ USA |
Biogen BIIB | 144,800,000 | -18.27% | ๐บ๐ธ USA |
Dow DOW | 703,600,000 | 297.13% | ๐บ๐ธ USA |
Gilead Sciences GILD | 1,248,000,000 | 604.40% | ๐บ๐ธ USA |
Merck MRK | 2,554,166,667 | 1,341.64% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | 125,220,000 | -29.32% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | 188,219,000 | 6.24% | ๐บ๐ธ USA |